Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaignGlobeNewsWire • 11/01/23
Danaher appoints Christopher Riley to Executive Vice President for BiotechnologyPRNewsWire • 10/31/23
The weight-loss drugs are coming for these companies — but here's why Coke, others, may be spared, says JPMorganMarket Watch • 10/24/23
Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation's Proposed Acquisition of AbcamBusiness Wire • 10/23/23
7 Stocks to Buy Before They Become the Next Trillion-Dollar Companies: October EditionInvestorPlace • 10/19/23
Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation's Proposed Acquisition of AbcamBusiness Wire • 10/17/23
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the CompanyGlobeNewsWire • 10/16/23
Exlusive: Why Abcam founder believes Danaher's acquisition offer falls shortProactive Investors • 10/16/23
Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to DanaherBusiness Wire • 10/12/23
ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCMBusiness Wire • 10/10/23